Safety, Pharmacokinetics, and Food Effect of the RORα Agonist TB-840, a Novel Candidate for Metabolic Dysfunction-Associated Steatohepatitis (MASH): A Randomized First-in-Human Study in Healthy Volunteers
RORα激动剂TB-840（一种治疗代谢功能障碍相关脂肪性肝炎（MASH）的新型候选药物）的安全性、药代动力学和食物效应：一项在健康志愿者中进行的随机首次人体研究
期刊:Life-Basel
影响因子:3.4
doi:10.3390/life15091410
Hwang, Inyoung; Lee, Shi-Ra; Kim, Heung Jae; Kim, Yun; Lee, Sang Won
